ÌÇÐÄÆƽâ°æ

The North American and Caribbean region spent some 439 billion U.S. dollars on health care for people with diabetes in 2024. At that time, health care expenditures due to diabetes were the lowest in Africa and Southeast Asia. 

Global healthcare expenditure

In 2024, diabetes-related health expenditure was by far the highest in the United States, with roughly 404.5 billion U.S. dollars, followed by China with  169  billion and Brazil with 45 billion U.S. dollars. Globally, an estimated one trillion U.S. dollars was spent on diabetes-related healthcare in 2024, meaning around 40 percent of the global expenditures for the treatment of diabetes was spent in the United States. Global healthcare spending for the condition is projected to grow to an estimated 1.04 trillion U.S. dollars by 2050. 

Diabetes-related mortality

In 2024, around 1.2 million Ìý±è±ð´Ç±è±ô±ð died as a result of diabetes before the age of 80 in the Western Pacific, while the Europe saw around 433 thousand diabetes-related deaths. The Western Pacific also has the highest number of people between the ages of 20 and 79 with undiagnosed diabetes: in 2024, there were about 107.6 million undiagnosed diabetes cases in the Western Pacific region, while approximately 45.6  million Southeast Asians had undiagnosed diabetes.